Drug development and working with specialised Rare Disease networks
pharmaphorum
DECEMBER 21, 2021
During the course of the webinar, Keefer explained how specialty sites, with deep knowledge on one or certain groups of Rare Diseases, are crucial for further progress in drug development to progress the number of treatments available to Rare Disease patients and to provide support to those individuals. The potential to leverage genomic data.
Let's personalize your content